The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.
A series of 28 exenterations for advanced pelvic tumours is presented. The operative mortality (within 90 days) was 17.8%. The actuarial survival (expressed as a two-year disease-free interval) was 35.7%, and better in cases with negative lymph nodes. The types of urinary and bowel diversions adopted are discussed in terms of longer survival.
D'Addato
F
F
Department of Gynaecology and Obstetrics, University of Turin, Italy.
Guercio
E
E
Re
A
A
Gatti
M
M
Raspollini
M
M
Proserpio
D
D
Bellino
R
R
Lanza
A
A
D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery*; D010385:Pelvic Exenteration / Q000379:methods / Q000401:mortality; D010386:Pelvic Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D012086:Reoperation